John Han

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial

Robert D. Inman, John C. Davis, Désirée van der Heijde et al. · Arthritis & Rheumatism · 2008 · 590 citations

Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial

Josef S Smolen, Désirée van der Heijde, E. William St. Clair et al. · Arthritis & Rheumatism · 2006 · 433 citations · Full text

The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: A large, randomized, placebo‐controlled trial

René Westhovens, David E. Yocum, John Han et al. · Arthritis & Rheumatism · 2006 · 311 citations

Pharmacotherapy, Inflammatory Arthritis, Inflammation +20

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double‐blind, placebo‐controlled, dose‐ranging study

Jonathan Kay, Eric L. Matteson, Bhaskar DasGupta et al. · Arthritis & Rheumatism · 2008 · 295 citations

Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double‐blind, placebo‐controlled magnetic resonance imaging study

Jürgen Braun, Robert B M Landewé, Kay‐Geert Hermann et al. · Arthritis & Rheumatism · 2006 · 242 citations